The international Prognostic Index for patients with CLL (CLL-IPI): An international meta-analysis

被引：0

作者：

Kutsch, Nadine

Bahlo, Jasmin

Byrd, John C.

Dohner, Hartmut

Eichhorst, Barbara

Else, Monica

Geisler, Christian

Grever, Michael R.

Lepretre, Stephane

Bergman, Manuela

Neuberg, Donna S.

Oscier, David

Rosenquist, Richard

Robak, Tadeusz

Shanafelt, Tait D.

Stilgenbauer, Stephan

Hallek, Michael J.

机构：

[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

[2] Univ Hosp Cologne, Ctr Integrated Oncol Cologne Bonn, Cologne, Germany

[3] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

[4] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany

[5] Inst Canc Res London, Div Mol Pathol, London, England

[6] Rigshosp, DK-2100 Copenhagen, Denmark

[7] Ohio State Univ, Columbus, OH 43210 USA

[8] Henri Becquerel Hosp, Rouen, France

[9] Klinikum Schwabing, Dept Hematol Oncol Immunol Palliat Care Infect Di, Munich, Germany

[10] Dana Farber Canc Inst, Boston, MA 02115 USA

[11] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England

[12] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden

[13] Med Univ Lodz, Lodz, Poland

[14] Mayo Clin, Rochester, MN USA

[15] Univ Hosp Ulm, Ulm, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7002

引用

页数：1

共 50 条

[31] Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) and Validation of a Proposed Novel Risk Model (BALL Score) in Real-World Relapsed/Refractory (R/R) CLL Patients Receiving Idelalisib and Rituximab
Gentile, Massimo
Reda, Gianluigi
Mauro, Francesca Romana
Sportoletti, Paolo
Laurenti, Luca
Coscia, Marta
Recchia, Anna G.
Varettoni, Marzia
Murru, Roberta
Chiarenza, Annalisa
Condoluci, Adalgisa
Moia, Riccardo
Pietrasanta, Daniela
Loseto, Giacomo
Consoli, Ugo
Scortechini, Ilaria
Vigna, Ernesto
Botta, Cirino
Fraticelli, Vincenzo Ludovico
Di Prima, Alessio
Tripepi, Giovanni
Rossi, Davide
Gaidano, Gianluca
Gattei, Valter
Morabito, Fortunato
[J]. BLOOD, 2019, 134
[32] The CLL-IPI applied in a population-based cohort
da Cunha-Bang, Caspar
Christiansen, Ilse
Niemann, Carsten Utoft
[J]. BLOOD, 2016, 128 (17) : 2181 - +
[33] Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment
Gentile, Massimo
Shanafelt, Tait D.
Mauro, Francesca Romana
Reda, Gianluigi
Rossi, Davide
Laurenti, Luca
Del Principe, Maria Ilaria
Cutrona, Giovanna
Angeletti, Ilaria
Coscia, Marta
Herishanu, Yair
Chiarenza, Annalisa
Molica, Stefano
Ciolli, Stefania
Goldschmidt, Neta
Angrilli, Francesco
Giordano, Annamaria
Rago, Angela
Bairey, Osnat
Tripepi, Giovanni
Chaffee, Kari G.
Sameer, Parikh A.
Vigna, Ernesto
Zirlik, Katja
Shvidel, Lev
Innocenti, Idanna
Recchia, Anna Grazia
Di Raimondo, Francesco
Del Poeta, Giovanni
Cortelezzi, Agostino
Neri, Antonino
Ferrarini, Manlio
Gaidano, Gianluca
Kay, Neil E.
Polliack, Aaron
Foa, Robin
Morabito, Fortunato
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (05) : 703 - 706
[34] Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
Yucai Wang
Sara J. Achenbach
Kari G. Rabe
Tait D. Shanafelt
Timothy G. Call
Wei Ding
Saad S. Kenderian
Eli Muchtar
Jose F. Leis
Amber B. Koehler
Susan M. Schwager
James R. Cerhan
Susan L. Slager
Neil E. Kay
Sameer A. Parikh
[J]. Blood Cancer Journal, 11
[35] Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
Wang, Yucai
Achenbach, Sara J.
Rabe, Kari G.
Shanafelt, Tait D.
Call, Timothy G.
Ding, Wei
Kenderian, Saad S.
Muchtar, Eli
Leis, Jose F.
Koehler, Amber B.
Schwager, Susan M.
Cerhan, James R.
Slager, Susan L.
Kay, Neil E.
Parikh, Sameer A.
[J]. BLOOD CANCER JOURNAL, 2021, 11 (08)
[36] Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases
Gentile, Massimo
Shanafelt, Tait D.
Mauro, Francesca R.
Laurenti, Luca
Rossi, Davide
Molica, Stefano
Vincelli, Iolanda
Cutrona, Giovanna
Uccello, Giuseppina
Pepe, Sara
Vigna, Ernesto
Tripepi, Giovanni
Chaffee, Kari G.
Parikh, Sameer A.
Bossio, Sabrina
Recchia, Anna Grazia
Innocenti, Idanna
Pasquale, Raffaella
Neri, Antonino
Ferrarini, Manlio
Gaidano, Gianluca
Foa, Robin
Morabito, Fortunato
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (02) : E35 - E37
[37] The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
Parikh, Sameer A.
Rabe, Kari G.
Kay, Neil E.
Call, Timothy G.
Ding, Wei
Leis, Jose F.
Kenderian, Saad S.
Muchtar, Eli
Wang, Yucai
Koehler, Amber B.
Schwager, Susan M.
Lesnick, Connie E.
Kleinstern, Geffen
Van Dyke, Daniel
Hanson, Curtis A.
Braggio, Esteban
Slager, Susan L.
Shanafelt, Tait D.
[J]. BLOOD, 2021, 138 (02) : 149 - 159
[38] Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia
Gao, Rui
Du, Kaixin
Liang, Jinhua
Xia, Yi
Wu, Jiazhu
Li, Yue
Pan, Bihui
Wang, Li
Li, Jianyong
Xu, Wei
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
[39] Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data
Parviz, Mehdi
Brieghel, Christian
Agius, Rudi
Niemann, Carsten U.
[J]. BLOOD ADVANCES, 2022, 6 (12) : 3716 - 3728
[40] Telomere Length Is Associated with Epigenetic Programming in CLL and Is a Superior Predictor of Clinical Outcome with the Ability to Bifurcate Patients with the Same CLL-IPI Score
Norris, Kevin
Oakes, Christopher C.
Giacopelli, Brian
Shanafelt, Tait D.
Kay, Neil E.
Chaffee, Kari G.
Fegan, Christopher
Baird, Duncan M.
Pepper, Chris
[J]. BLOOD, 2018, 132

← 1 2 3 4 5 →